IONS – ionis pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Company News for Nov 7, 2024 [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target lowered by analysts at Wells Fargo & Company from $82.00 to $77.00. They now have an "overweight" rating on the stock.
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ionis to present at upcoming investor conferences
Form 144 IONIS PHARMACEUTICALS Filed by: Monia Brett P
Form 144 IONIS PHARMACEUTICALS Filed by: Swayze Eric
Form 144 IONIS PHARMACEUTICALS Filed by: LOSCALZO JOSEPH
Form SC 13G IONIS PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 10-Q IONIS PHARMACEUTICALS For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.